» Authors » Clement Sarrazin

Clement Sarrazin

Explore the profile of Clement Sarrazin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 38
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinar U, Sarrazin C, Anract J, Chevrot A, Fassi-Fehri H, Wilisch J, et al.
Fr J Urol . 2025 Mar; :102877. PMID: 40089020
Introduction: Benign prostatic hyperplasia (BPH) is a prevalent condition in ageing men, often resulting in significant lower urinary tract symptoms (LUTS) that impact quality of life. For patients with huge...
2.
Proye P, Gondran-Tellier B, Michel F, Bensalah K, Bigot P, Audenet F, et al.
Eur Urol Open Sci . 2025 Mar; 73:60-67. PMID: 40034716
Background And Objective: A renal mass biopsy (RMB) is not systematically recommended before surgical excision of a renal mass, although it has demonstrated elevated accuracy in determining renal masses with...
3.
Bazinet A, Sarrazin C, Weis S, Thuillier C, Madec F, Boillot B
Fr J Urol . 2024 Oct; 35(2):102757. PMID: 39393536
Introduction: Cutaneous stoma stenosis represents a frequent complication associated with continent catheterizable channel, often necessitating recurrent patients' consultation, hospital admission, and repetitive surgical interventions. Management strategies encompass dilatation, incision, and,...
4.
Garnier T, Lesprit P, Sarrazin C, Descotes J, Pavese P, Fiard G
Fr J Urol . 2024 Sep; 34(13):102745. PMID: 39299563
In the presence of a positive preoperative urine culture, the prescription of a preoperative antibiotic therapy is recommended. The choice of antibiotic therapy and prescription are usually made by the...
5.
Sarkis J, Champy C, Doumerc N, Bruyere F, Roupret M, Branger N, et al.
Eur Urol Oncol . 2024 Jun; 7(6):1487-1496. PMID: 38937207
Background And Objective: A hilar location for a renal tumour is sometimes viewed as a limiting factor for safe partial nephrectomy. Our aim was to evaluate perioperative, oncological, and functional...
6.
Reichmann J, Sarrazin C, Schmale S, Blaurock C, Balkema-Buschmann A, Schmitzer B, et al.
Sci Rep . 2024 May; 14(1):12348. PMID: 38811688
X-ray Phase Contrast Tomography (XPCT) based on wavefield propagation has been established as a high resolution three-dimensional (3D) imaging modality, suitable to reconstruct the intricate structure of soft tissues, and...
7.
Sarrazin C, Windisch O, Baron M, Boillot B, Thuillier C, Lefevre C, et al.
J Urol . 2023 Feb; 209(6):1176-1183. PMID: 36812396
Purpose: We assess the efficacy, safety, and predictive factors for failure of synthetic mid-urethral slings for the treatment of urinary incontinence in a large cohort of women with neurogenic lower...
8.
Sarrazin C, Baron M, Thuillier C, Ruffion A, Perrouin-Verbe M, Fiard G
Int Urogynecol J . 2021 Aug; 33(4):767-776. PMID: 34402935
Introduction And Hypothesis: The aim of our study was to evaluate the efficiency and safety of synthetic mid-urethral slings (sMUS) for the treatment of stress urinary incontinence (SUI) in women...
9.
Giacosa S, Pillet C, Seraudie I, Guyon L, Wallez Y, Roelants C, et al.
Cancers (Basel) . 2021 Feb; 13(3). PMID: 33540838
Kinase-targeted agents demonstrate antitumor activity in advanced metastatic clear cell renal cell carcinoma (ccRCC), which remains largely incurable. Integration of genomic approaches through small-molecules and genetically based high-throughput screening holds...
10.
Roelants C, Pillet C, Franquet Q, Sarrazin C, Peilleron N, Giacosa S, et al.
Cancers (Basel) . 2020 Jan; 12(1). PMID: 31963500
Clear cell renal cell carcinoma (ccRCC) is the third type of urologic cancer. At time of diagnosis, 30% of cases are metastatic with no effect of chemotherapy or radiotherapy. Current...